The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
Despite improvements in awareness and treatment of type II diabetes mellitus (TIIDM), this disease remains a major source of morbidity and mortality worldwide, and prevalence continues to rise. Oxidative damage caused by free radicals has long been known to contribute to the pathogenesis and progres...
Saved in:
Main Authors: | Joshua A. David, William J. Rifkin, Piul S. Rabbani, Daniel J. Ceradini |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2017/4826724 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Nrf2/KEAP1 signaling pathway using bioactive compounds to combat mastitis
by: Muhammad Zahoor Khan, et al.
Published: (2025-02-01) -
KLF5 promotes esophageal squamous cell carcinoma radioresistance by targeting the Keap1-Nrf2 pathway
by: Yang Wang, et al.
Published: (2025-02-01) -
Protective Effect of Uric Acid on ox-LDL-Induced HUVECs Injury via Keap1-Nrf2-ARE Pathway
by: Yajuan Lin, et al.
Published: (2021-01-01) -
The discovery and characterization of K‐563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp
by: Ran Hori, et al.
Published: (2019-03-01) -
The protective roles of eugenol on type 1 diabetes mellitus through NRF2-mediated oxidative stress pathway
by: Yalan Jiang, et al.
Published: (2025-01-01)